Weight-loss conversations tend to be marketed towards women. But in Hong Kong, over 50% of men are classified as overweight or obese(Based on clinical guidelines and prescribing information) — and the type of fat men carry is arguably the most dangerous kind.
GLP-1 medications work just as effectively for men as for women. For men carrying excess abdominal weight, these medications may offer benefits that go far beyond the number on the scale.
→ For a complete overview, see our Complete Guide to GLP-1 Weight Loss in Hong Kong.
Men tend to accumulate fat around the abdomen — the classic "beer belly" or "dad bod." This isn't just subcutaneous fat (under the skin). Much of it is visceral fat: fat that wraps around internal organs including the liver, pancreas, and intestines.
Visceral fat is metabolically active. It releases inflammatory compounds and hormones that directly contribute to(Based on clinical guidelines and prescribing information):
A man with a normal BMI but a large waist circumference may be at higher cardiometabolic risk than someone with a higher BMI but less central fat(Based on clinical guidelines and prescribing information).
GLP-1 receptor agonists don't just reduce total body weight — they preferentially reduce visceral fat and improve body composition:
GLP-1 works through multiple pathways relevant to visceral fat (Drucker DJ. Cell Metab. 2018;27(4):740-756. PMID: 29617641):
In the STEP 1 trial, male participants receiving semaglutide 2.4 mg showed significant reductions in waist circumference — a proxy measure for visceral fat (Wilding JPH et al. N Engl J Med. 2021;384(11):989-1002. PMID: 33567185).
In the SURMOUNT-1 trial, tirzepatide produced even larger waist-circumference reductions across all dose groups (Jastreboff AM et al. N Engl J Med. 2022;387(3):205-216. PMID: 35658024).
Imaging studies using DEXA scans and MRI have confirmed that GLP-1 treatment preferentially reduces visceral fat relative to subcutaneous fat(Based on clinical guidelines and prescribing information).
Visceral fat loss translates directly to cardiovascular risk reduction: - Lower blood pressure(Based on clinical guidelines and prescribing information) - Improved lipid profile (lower triglycerides, higher HDL)(Based on clinical guidelines and prescribing information) - Reduced arterial inflammation(Based on clinical guidelines and prescribing information)
The SELECT trial demonstrated that semaglutide reduced major cardiovascular events (heart attack, stroke, cardiovascular death) by 20% in patients with overweight/obesity and established cardiovascular disease(Based on clinical guidelines and prescribing information).
The relationship between obesity and testosterone is bidirectional: - Excess visceral fat → lower testosterone (via aromatase conversion) - Lower testosterone → increased fat storage → more visceral fat
Weight loss through GLP-1 medication can break this cycle. Studies show that significant weight loss (>10% body weight) is associated with meaningful increases in testosterone levels(Based on clinical guidelines and prescribing information).
This has downstream effects on: - Energy and vitality - Muscle mass maintenance - Sexual function - Mood and cognitive clarity
For optimal results, GLP-1 medication should be combined with a structured exercise programme:
Many Hong Kong men avoid seeking help for weight management due to: - Perception that weight loss is "not a men's issue" - Reluctance to visit clinics for what they see as a cosmetic concern - Lack of awareness that abdominal obesity is a serious medical risk - Cultural norms around body image for men
The reality: obesity is a medical condition with serious health consequences. GLP-1 treatment is evidence-based medicine, not vanity. And with noah™'s online platform, you don't need to sit in a waiting room to get help.
noah™ provides discreet, doctor-led weight management designed to fit into a busy professional life:
GLP-1 medications do not directly affect testosterone. However, the weight loss they produce — particularly visceral fat loss — is associated with increased testosterone levels in men(Based on clinical guidelines and prescribing information).
Yes, though it requires deliberate effort. Adequate protein intake and consistent resistance training are essential. Some patients find it challenging to eat enough protein due to reduced appetite — planning meals around protein sources helps.
During the initial dose-escalation phase, reduced caloric intake and GI side effects may temporarily affect energy levels. Most men find they adapt within a few weeks. Timing your injection and meals around workouts can help.
Inform your noah™ doctor about all supplements, including protein powders, creatine, pre-workout formulas, and vitamins. Most common supplements are compatible, but your doctor should be aware of everything you're taking.
GLP-1 medication addresses the root cause of low testosterone in overweight men (excess visceral fat) rather than replacing the hormone directly. For men with clinically low testosterone due to other causes, TRT may still be appropriate — this should be discussed with your doctor.
This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any medication. Treatment suitability is determined by your prescribing doctor based on your individual health profile.
© 2026 noah™. All rights reserved.

